1. Home
  2. UEC vs GKOS Comparison

UEC vs GKOS Comparison

Compare UEC & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UEC
  • GKOS
  • Stock Information
  • Founded
  • UEC 2003
  • GKOS 1998
  • Country
  • UEC United States
  • GKOS United States
  • Employees
  • UEC N/A
  • GKOS N/A
  • Industry
  • UEC Other Metals and Minerals
  • GKOS Medical/Dental Instruments
  • Sector
  • UEC Basic Materials
  • GKOS Health Care
  • Exchange
  • UEC Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • UEC 6.5B
  • GKOS 5.4B
  • IPO Year
  • UEC N/A
  • GKOS 2015
  • Fundamental
  • Price
  • UEC $12.19
  • GKOS $91.41
  • Analyst Decision
  • UEC Strong Buy
  • GKOS Strong Buy
  • Analyst Count
  • UEC 5
  • GKOS 13
  • Target Price
  • UEC $15.80
  • GKOS $122.08
  • AVG Volume (30 Days)
  • UEC 14.3M
  • GKOS 1.6M
  • Earning Date
  • UEC 12-04-2025
  • GKOS 10-29-2025
  • Dividend Yield
  • UEC N/A
  • GKOS N/A
  • EPS Growth
  • UEC N/A
  • GKOS N/A
  • EPS
  • UEC N/A
  • GKOS N/A
  • Revenue
  • UEC $66,837,000.00
  • GKOS $469,820,000.00
  • Revenue This Year
  • UEC $4.84
  • GKOS $30.89
  • Revenue Next Year
  • UEC $103.03
  • GKOS $24.36
  • P/E Ratio
  • UEC N/A
  • GKOS N/A
  • Revenue Growth
  • UEC 29737.94
  • GKOS 30.38
  • 52 Week Low
  • UEC $3.85
  • GKOS $73.16
  • 52 Week High
  • UEC $17.80
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • UEC 41.93
  • GKOS 62.12
  • Support Level
  • UEC $11.36
  • GKOS $80.91
  • Resistance Level
  • UEC $13.17
  • GKOS $102.80
  • Average True Range (ATR)
  • UEC 0.90
  • GKOS 4.61
  • MACD
  • UEC -0.33
  • GKOS 1.16
  • Stochastic Oscillator
  • UEC 18.39
  • GKOS 61.56

About UEC Uranium Energy Corp.

Uranium Energy Corp is a uranium mining company engaged in the exploration, extraction, and processing of uranium and titanium concentrates across projects in the United States, Canada, and Paraguay. The Company operates through multiple segments, including uranium mining activities in Wyoming, Texas, Saskatchewan, and other regions, along with a corporate segment focused on investments and uranium inventory trading. It is expanding its portfolio of low-cost uranium projects in stable North American locations and operates a Wyoming-based ISR (In-Situ Recovery) Hub and Spoke platform. This platform is supported by two fully operational central processing plants and seven U.S. ISR uranium projects.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: